Center for Wound Treatment joins national trial

Farrell and Greenville, PA — The UPMC Horizon Center for Wound Treatment has joined a national clinical trial to test the effectiveness of a new drug used for treating diabetic foot ulcers.

According to the Centers for Disease Control and Prevention, about 15 percent of all diabetic patients will develop a foot ulcer during their lifetimes. These foot ulcers are open wounds that typically occur on the bottom of the foot.

The goal of trial is to test the safety and effectiveness of an investigational topical gel for diabetic foot ulcers. The medication may offer a therapeutic option to patients affected by chronic foot wounds.

“We’re very excited to be part of this national research effort to reduce the amputation rate of patients who suffer from diabetic foot ulcers,” says Thomas Serena, MD, medical director of the Center for Wound Treatment.

Participants in the clinical trial will be compensated for time and travel and will receive free study-related materials and lab visits. The study is expected to last at least five months.

Anyone who suffers from chronic foot wounds related to diabetes who are interested in participating in the clinical trial should call Becky Fry, enterostomal therapist, at 724-589-6254.

Contact: Erin Palko, public relations manager, 724-589-8107